BioCatalyst

Tafasitamab, Lenalidomide, Rituximab, Cyclophosphamide — catalyst calendar

1 verified catalyst event(s) referencing Tafasitamab, Lenalidomide, Rituximab, Cyclophosphamide, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-01
in 2mo
ESTIMATED
 READOUT
Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-interm
Phase 3 · Diffuse Large B-cell Lymphoma
 INCY INCYTE CORP Tafasitamab, Lenalidomide, Rituximab, Cy ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.